Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S.J. Rodig
Clinical and Biological Evaluation of the Novel Cd30/Cd16a Tetravalent Bispecific Antibody (Afm13) in Relapsed or Refractory Cd30-Positive Lymphoma With Cutaneous Presentation: A Biomarker Phase Ib/Iia Study (Nct03192202)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma
Malignant tumours
Brentuximab Vedotin for Relapsed or Refractory CD30+ Hodgkin Lymphoma: A Multicenter Analysis From Asia
OncoTargets and Therapy
Oncology
Pharmacology
Final Data From the Phase 3 Alcanza Study: Brentuximab Vedotin (Bv) vs Physician's Choice (Pc) in Patients (Pts) With Cd30-Positive (Cd30+) Cutaneous T-Cell Lymphoma (Ctcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial
The Lancet
Medicine
CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase Iia Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Primary Cutaneous CD30-positive Large T-Cell Lymphoma With Secondary Lymph Node Involvement Detected by Sentinel Lymphonodectomy
Acta Dermato-Venereologica
Dermatology
Medicine
